Latent form of transforming growth factor-β1 acts as a potent growth inhibitor on a human erythroleukemia cell line
- 1 February 1990
- journal article
- research article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 167 (1), 27-32
- https://doi.org/10.1016/0006-291x(90)91725-8
Abstract
No abstract availableFunding Information
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 17 references indexed in Scilit:
- Production of transforming growth factor beta by human peripheral blood monocytes and neutrophilsJournal of Cellular Physiology, 1989
- Inhibition of endothelial cell movement by pericytes and smooth muscle cells: activation of a latent transforming growth factor-beta 1-like molecule by plasmin during co-culture.The Journal of cell biology, 1989
- Role for carbohydrate structures inTGF-β1 latencyNature, 1989
- Transforming growth factor β: Possible roles in the regulation of normal and leukemic hematopoietic cell growthJournal of Cellular Biochemistry, 1989
- Activation of the bone-derived latent TGF beta complex by isolated osteoclastsBiochemical and Biophysical Research Communications, 1989
- One of two subunits of masking protein in latent TGF‐β is a part of pro‐TGF‐βFEBS Letters, 1989
- Recombinant TGF-β1 is Synthesized as a Two-Component Latent Complex that Shares Some Structural Features with the Native Platelet Latent TGF-β1 ComplexGrowth Factors, 1989
- Proteolytic activation of latent transforming growth factor-beta from fibroblast-conditioned medium.The Journal of cell biology, 1988
- An improved method of purification of transforming growth factor, type β from plateletsAnalytical Biochemistry, 1988
- Distribution and modulation of the cellular receptor for transforming growth factor-beta.The Journal of cell biology, 1987